IRIS
CAPODANNO, DAVIDE FRANCESCO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.977
EU - Europa 5.873
AS - Asia 2.105
AF - Africa 540
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 3
Totale 18.513
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.334
IE - Irlanda 1.941
CN - Cina 1.801
UA - Ucraina 1.790
IT - Italia 673
CA - Canada 642
RU - Federazione Russa 500
CI - Costa d'Avorio 463
SE - Svezia 281
GR - Grecia 194
VN - Vietnam 167
DE - Germania 104
GB - Regno Unito 84
CH - Svizzera 60
SN - Senegal 59
FR - Francia 58
FI - Finlandia 37
AT - Austria 35
IN - India 32
NL - Olanda 32
UZ - Uzbekistan 32
SG - Singapore 28
BE - Belgio 26
PL - Polonia 21
NG - Nigeria 16
EU - Europa 15
HK - Hong Kong 11
JP - Giappone 10
LB - Libano 9
BG - Bulgaria 8
CZ - Repubblica Ceca 8
BY - Bielorussia 3
ES - Italia 3
NZ - Nuova Zelanda 3
PH - Filippine 3
PT - Portogallo 3
GE - Georgia 2
MK - Macedonia 2
MY - Malesia 2
RO - Romania 2
TR - Turchia 2
BN - Brunei Darussalam 1
BZ - Belize 1
DK - Danimarca 1
IR - Iran 1
IS - Islanda 1
KE - Kenya 1
KR - Corea 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 18.513
Salva come PNG Salva come JPEG
Città #
Jacksonville 2.375
Dublin 1.939
Chandler 1.400
Nanjing 640
Houston 619
Lawrence 542
Andover 537
Cambridge 535
Toronto 498
Abidjan 463
Des Moines 377
Ashburn 372
Catania 340
Boardman 338
San Mateo 230
Nanchang 227
Wilmington 186
Hebei 177
Shenyang 158
Dong Ket 143
Athens 136
Ottawa 135
Jiaxing 115
Saint Petersburg 114
Tianjin 112
Changsha 90
Dakar 59
Washington 57
Beijing 45
Bremen 43
Moscow 43
Norwalk 39
Seattle 39
Hangzhou 37
Kunming 34
Lappeenranta 33
Jinan 30
Ningbo 29
Brussels 26
Den Haag 24
Hanoi 24
Liberty Lake 24
Pune 24
Zhengzhou 22
Gravina di Catania 18
Ann Arbor 17
Abuja 16
Edinburgh 16
Milan 16
Taizhou 16
Frankfurt Am Main 14
Los Angeles 13
Pozzo Di Gotto 13
Falls Church 12
Manduria 12
Padova 11
Palermo 11
Aigaleo 10
Changchun 10
Redwood City 10
Hong Kong 9
Kiev 9
Lausanne 9
Guangzhou 8
Rome 8
Acireale 7
Lanzhou 7
Princeton 7
Tappahannock 7
Fairfield 6
Ludwigshafen 6
Providence 6
Shanghai 6
Canicattini Bagni 5
Civitavecchia 5
Maletto 5
Mascalucia 5
Scicli 5
Stein 5
Stockholm 5
Casarano 4
Fuzhou 4
Helsinki 4
Woodbridge 4
Amsterdam 3
Bisceglie 3
Chicago 3
Dearborn 3
Groningen 3
Lisbon 3
Manfredonia 3
Naples 3
Pavia 3
Phoenix 3
Piraeus 3
Redmond 3
Singapore 3
Taranto 3
Tokyo 3
Aprilia 2
Totale 13.838
Salva come PNG Salva come JPEG
Nome #
Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis of 50,578 patients 492
Neoatherosclerosis as the cause of late failure of a bioresorbable vascular scaffold 207
Incorporating glomerular filtration rate or creatinine clearance by the modification of diet in renal disease equation or the Cockcroft-Gault equations to improve the global accuracy of the Age, Creatinine, Ejection Fraction [ACEF] score in patients undergoing percutaneous coronary intervention 106
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds versus Everolimus-Eluting Stents: a Propensity Matched Comparison of the GHOST-EU and XIENCE V USA Registries 97
A Risk Model for Prediction of One-Year Mortality in Patients Undergoing MitraClip Implantation 88
Miocardio non compattato del ventricolo sinistro e aneurisma del setto interatriale con difetto. Associazione casuale? 64
Predictive Accuracy of CHA2DS2-VASc and HAS-BLED Scores In Patients Without Atrial Fibrillation Undergoing Percutaneous Coronary Intervention And Discharged On Dual Antiplatelet Therapy 61
Prevalence of renal artery stenosis in patients undergoing cardiac catheterization 60
Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry. 58
Pre-dilation, Sizing and Post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffolds implantation for prediction of cardiac adverse events: development and internal validation of the PSP score 56
Quality of life assessment after percutaneous aortic valve implantation 55
Clinical implication of different plaque distribution patterns in distal left main coronary artery 55
Transcatheter aortic valve implantation in 2017: state of the art 55
Vascular response and healing profile of everolimus-eluting bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: A one-year optical coherence tomography analysis from the GHOST-CTO registry 55
[Management of severe stenosis controversies and promises] 54
Cigarette Smoking is Associated with a Dose-Response Effect in Clopidogrel Treated Patients with Diabetes Mellitus and Coronary Artery Disease: Results of a Pharmacodynamic Study 54
Standardised Definitions of Structural Deterioration and Valve Failure in Assessing Long-Term Durability of Transcatheter and Surgical Aortic Bioprosthetic Valves: A Consensus Statement from The European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) 54
Clinical decision making in left main revascularization: the past, the present and the future 53
Antithrombotic Therapy for Secondary Prevention in Patients with Cerebrovascular Disease 52
Recent acquisitions and advances in the knowledge of coronary flow disturbances after percutaneous coronary intervention 52
Is the metallic stent a safe treatment for bioresorbable scaffold failure? Insights from optical coherence tomography 52
Temporal patterns of early neointimal strut coverage of the CATANIA stent compared with drug eluting stents and bare metal stent: the Rapid Evaluation of Vessel Healing after Angioplasty (REVEAL) trial 51
Intraoperative defibrillation threshold testing durino implantable cardioverter-defibrillator insertion: Do we really need it? 51
Local delivery versus intracoronary infusion of abciximab in patients with acute coronary syndromes 51
Very Late Outcomes of Drug-Eluting Stents: The "Catch-Down" Phenomenon 51
A comparison between Endeavor and Endeavor Resolute drug-eluting stents: outcome at six months follow up 51
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry. 51
Long-term bleeding events in patients with prolonged dual antiplatelet therapy after DES implantation 51
Diabetes mellitus: the scary killer haunting silently 50
Antithrombotic Therapy in Patients with Chronic Kidney Disease 50
A focused update on emerging prognostic determinants in distal left main percutaneous coronary intervention 50
The treatment of coronary bifurcation lesions with bioresorbable vascular scaffolds 50
Effects of Cangrelor in Coronary Artery Disease Patients With and Without Diabetes Mellitus: An In Vitro Pharmacodynamic Investigation 50
A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score 50
Association of tricuspid regurgitation with clinical and echocardiographic outcomes after percutaneous mitral valve repair with the MitraClip System: 30-day and 12-month follow-up from the GRASP Registry 49
Association of Tricuspid Regurgitation With Clinical and Echocardiographic Outcomes After Percutaneous Mitral Valve Repair With the MitraClip System: Thirty-Day and Twelve-Month Follow-up From the GRASP Registry 49
Feasibility and Predictors of Early Discharge After Percutaneous Edge-to-Edge Mitral Valve Repair 49
Pretreatment with Antiplatelet Agents in the Setting of Percutaneous Coronary Intervention: When and Which Drugs? 49
CORONARY REMODELLING AFTER RECANALIZATION OF CHRONIC TOTAL OCCLUSION 49
Spontaneous coronary artery dissection 48
Upcoming TAVI trials: rationale, design and likely impact on clinical practice 48
Reply: Validity of Randomized Trials Comparing Radial Versus Femoral Access in Acute Coronary Syndrome 48
Early, late and very late incidence of bioresorbable scaffold thrombosis: a systematic review and meta-analysis of randomized clinical trials and observational studies 48
Impact of race and gender on antithrombotic therapy 48
The inflammatory abdominal aortic aneurysm and coronary artery disease. Case report and review 48
Optimal P2Y12 inhibitor for primary PCI in STEMI: Network meta-analysis in the data-fre zone. Do you believe in magic? 48
Fate of Non-Culprit Plaques in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Followed by Statin Therapy: A Serial Optical Coherence Tomography Analysis From the OCTAVIA Study 48
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2 48
Acute Left Atrial Spontaneous Echo Contrast and Suspicious Thrombus Formation Following Mitral Regurgitation Reduction With The MitraClip System 48
Effect of post-procedural evidence-based therapy on 2-year prognosis after transcatheter mitral valve repair 47
EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention 47
Usefulness of 3D OCT to Diagnose a Noncircumferential Open-Cell Stent Fracture 47
Three-Dimensional Angle Assessment and Plaque Distribution Classification in Left Main Disease: Impact of Geometry on Outcome 47
Tailoring duration of DAPT with risk scores 47
Haemostatic Profiles Assessed by Thromboelastography in Patients with End-Stage Renal Disease 47
Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft Surgery in Left Main Coronary Artery Disease: a Meta-Analysis of Randomized Clinical Data 47
Emerging strategies for rapid reversal of anticoagulation in patients undergoing catheter-based interventions: aptamers enter the RADAR 47
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) 47
Update on clinical evidence (Part II): a summary of the main post market studies 47
Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary PCI 47
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation) 47
Early discharge in acute myocardial infarction after clinical and angiographic risk assessment 46
Mechanisms, Pathophysiology, and Clinical Aspects of Incomplete Stent Apposition 46
Reply: plaque rupture in stable coronary artery disease 46
Management issues of chronic therapy with non-vitamin K oral anticolagulants or antiplatelet agents: different or alike? 46
Bivalirudin For Acute Coronary Syndromes: Premises, Promises and Doubts 46
Bioresorbable vascular scaffold in patients with complex coronary artery disease. 46
New-onset coronary aneurism and late-acquired incomplete scaffold apposition after full polymer jacket of a chronic total occlusion with bioresorbable scaffolds 46
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST- EU Registry - Reply 46
Functional profile of the platelet P2Y12 receptor signaling pathway in patients with diabetes mellitus and coronary artery disease 46
Progresses in interventional cardiology: focus on patent foramen ovale, coronary intervention, antithrombotic pharmacology, and more 46
Volumetric Assessment of Lesion Severity with Optical Coherence Tomography: Relationship with Fractional Flow Reserve 46
Coronary revascularization strategies in patients with multivessel disease: is it all about diabetes? 46
Guideline-driven versus non-guideline driven approach for left main coronary artery revascularization: the Appraise a customized strategy for left main revascularization (CUSTOMIZE) study 46
Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography-Guided Percutaneous Coronary Intervention With Stent Implantation: A Systematic Review and Bayesian Network Meta-Analysis of 31 Studies and 17,882 Patients 46
Early and mid term clinical outcomes with the CATANIA coronary stent system versus bare metal stents in patients with coronary artery disease 46
Incidence of Long-Term Structural Valve Dysfunction and Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement 46
The Sicilian Drug-eluting Stent Registry - Risk-benefits and Cost-effectiveness Analyses of Drug-eluting Stents versus Bare-metal Stents 45
Unraveling the EXCEL: Promises and Challenges of the Next Trial of Left Main Percutaneous Coronary Intervention 45
Does the SYNTAX score get on your nerves? Practical considerations on how and when avoiding it to maximize its usefulness with no waste of time 45
Radial access reduces mortality in patients with acute coronary syndromes. Results from an updated trial sequential analysis of randomized trials 45
Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary artery 45
The optimal pharmacological formula for percutaneous coronary intervention 45
Antiplatelet and anticoagulant therapy in elderly patients 45
Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting 45
Lo studio PRAMI 45
Strategies and Outcomes of Repeat Mitral Valve Interventions After Failed MitraClip Therapy 45
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 45
Head-to-head comparison of early vessel healing by optical coherence tomography after implantation of different stents in the same patient 45
Platelet function profiles in the elderly: Results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivity. 45
Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Association (ACCA) 45
Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) 45
Long-Term Follow-Up after Drug Eluting Stent Implantation in Left Main Trifurcations 44
Antiplatelet Therapy: New Pharmacological Agents and Changing Paradigms 44
Bridging antiplatelet therapy in patients requiring cardiac and non-cardiac surgery: from bench to bedside 44
Long term outcome of patients with chronic total occlusions: the value of monitoring percutaneous coronary intervention by non-invasive imaging 44
L'angioplastica complessa al posto del by-pass: ruolo degli score di rischio 44
Pre-Defining Optimal C-Arm Position for TAVI With CT-Scan Using a Free Software 44
A Multidisciplinary Consensus Document on Follow-up Strategies for Patients Treated with Percutaneous Coronary Intervention 44
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. 44
Totale 5.589
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.479
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.479
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019168 0 0 0 0 0 0 0 0 0 0 35 133
2019/20203.624 1.300 236 319 154 361 47 486 6 235 48 285 147
2020/20213.251 12 231 498 8 834 113 501 6 269 24 525 230
2021/20223.809 500 586 11 51 626 12 565 100 335 5 84 934
2022/20235.283 552 69 41 361 688 1.004 11 828 1.459 35 172 63
2023/20241.692 129 503 114 195 100 379 52 111 17 79 13 0
Totale 19.258